CLINICAL_TRIALS
trial_result
· 2023-08-21
Clinical Trial Update: Use of Bevacizumab in Trabeculectomy Surgery [Phase 4]
Summary
Phase 4 trial updates the use of bevacizumab as an adjunct in trabeculectomy surgery for glaucoma, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sunnybrook Health Sciences Centre | Conditions: Glaucoma, Optic Neuropathy | Phase 4 | Status: COMPLETED | Results posted: 2023-08-21